Dosar de subiect

Sanatate

Rezultate promitatoare pentru un nou medicament contra cancerului ovarian si uterin

Primul articol: 12 apr. 2026, 18:02 | Ultima actualizare: 12 apr. 2026, 18:02 | 1 sursa | 1 articol
#cancer#medicament#sanatate

Mai multe surse. Mai putina manipulare.

Analiza editoriala

Bazat pe 1 sursa, 1 articol

Compania farmaceutica GSK a raportat rezultate promitatoare in studiile initiale ale unui nou medicament destinat tratarii cancerului ovarian si uterin. Aceste descoperiri ar putea reprezenta un progres semnificativ in lupta impotriva acestor tipuri de cancer, oferind noi optiuni terapeutice pentru paciente. Studiile continua pentru a evalua eficacitatea si siguranta pe termen lung a medicamentului.

Articole despre acest subiect

GSK reports promising early results in ovarian and womb cancer drug trial Foto: The Guardian
The Guardian English Julia Kollewe 12 apr. 2026, 18:02 (acum 1 ora)

GSK reports promising early results in ovarian and womb cancer drug trial

Mo-Rez reduced or eliminated tumours in over 60% of patients and is expected to be a blockbuster drugGSK has revealed positive results for a treatment for gynaecological cancers as its chief executive, Luke Miels, steps up drug development efforts at the group.The company said that in an early-stage trial Mocertatug Rezetecan, known as Mo-Rez, shrank or eliminated tumours in 62% of patients with ovarian cancer where chemotherapy had failed, and in 67% of those with endometrial cancer. Continue r

Citeste pe The Guardian →